User profiles for "author:M Glickman"

Michael S Glickman

- Verified email at MSKCC.org - Cited by 10850

Mark Glickman

- Verified email at fas.harvard.edu - Cited by 8665

[HTML][HTML] The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction

MH Glickman, A Ciechanover - Physiological reviews, 2002 - journals.physiology.org
Between the 1960s and 1980s, most life scientists focused their attention on studies of
nucleic acids and the translation of the coded information. Protein degradation was a …

False discovery rate control is a recommended alternative to Bonferroni-type adjustments in health studies

ME Glickman, SR Rao, MR Schultz - Journal of clinical epidemiology, 2014 - Elsevier
Objectives Procedures for controlling the false positive rate when performing many
hypothesis tests are commonplace in health and medical studies. Such procedures, most …

The mechanism of action of BCG therapy for bladder cancer—a current perspective

G Redelman-Sidi, MS Glickman, BH Bochner - Nature reviews urology, 2014 - nature.com
Abstract Bacillus Calmette–Guérin (BCG) has been used to treat non-muscle-invasive
bladder cancer for more than 30 years. It is one of the most successful biotherapies for …

KDOQI clinical practice guideline for vascular access: 2019 update

CE Lok, TS Huber, T Lee, S Shenoy, AS Yevzlin… - American Journal of …, 2020 - Elsevier
Abstract The National Kidney Foundation's Kidney Disease Outcomes Quality Initiative
(KDOQI) has provided evidence-based guidelines for hemodialysis vascular access since …

[HTML][HTML] Determinants of COVID-19 disease severity in patients with cancer

EV Robilotti, NE Babady, PA Mead, T Rolling… - Nature medicine, 2020 - nature.com
Abstract As of 10 April 2020, New York State had 180,458 cases of severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) and 9,385 reported deaths. Patients with cancer …

[HTML][HTML] Inadequate management of blood pressure in a hypertensive population

…, EC Hickey, RH Friedman, M Glickman… - … England Journal of …, 1998 - Mass Medical Soc
Background Many patients with hypertension have inadequate control of their blood
pressure. Improving the treatment of hypertension requires an understanding of the ways in …

A gated channel into the proteasome core particle

M Groll, M Bajorek, A Köhler, L Moroder… - Nature structural …, 2000 - nature.com
The core particle (CP) of the yeast proteasome is composed of four heptameric rings of
subunits arranged in a hollow, barrel-like structure. We report that the CP is autoinhibited by …

[HTML][HTML] A subcomplex of the proteasome regulatory particle required for ubiquitin-conjugate degradation and related to the COP9-signalosome and eIF3

MH Glickman, DM Rubin, O Coux, I Wefes, G Pfeifer… - Cell, 1998 - cell.com
The proteasome consists of a 20S proteolytic core particle (CP) and a 19S regulatory
particle (RP), which selects ubiquitinated substrates for translocation into the CP. An eight …

TOX is a critical regulator of tumour-specific T cell differentiation

AC Scott, F Dündar, P Zumbo, SS Chandran… - Nature, 2019 - nature.com
Tumour-specific CD8 T cell dysfunction is a differentiation state that is distinct from the
functional effector or memory T cell states,,,,–. Here we identify the nuclear factor TOX as a …

Acute flank pain: comparison of non-contrast-enhanced CT and intravenous urography.

RC Smith, AT Rosenfield, KA Choe, KR Essenmacher… - Radiology, 1995 - pubs.rsna.org
PURPOSE: To compare non-contrast-enhanced computed tomography (CT) and
intravenous urography (IVU) in the evaluation of patients who present with acute flank pain …